Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Marvin S. Swartz, MD
JCP
Original Research
Heterogeneity of Treatment Effects of LAI Antipsychotics
November 27, 2018
Which subgroups of patients with schizophrenia or schizoaffective disorder may be prone to treatment failure? Is it men or women, old or young, or are more factors involved? Researchers...
T. Scott Stroup
,
Natalie A. Bareis
,
Robert A. Rosenheck
, et al
JCP
Original Research
Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia
September 21, 2010
Donald E. Addington
,
Somaia Mohamed
,
Robert A. Rosenheck
, et al
JCP
Original Research
Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia
August 10, 2010
Stanley N. Caroff
,
Vicki G. Davis
,
Del D. Miller
, et al
JCP
Original Research
Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care
March 15, 2006
Haya Ascher-Svanum
,
Douglas E. Faries
,
Baojin Zhu
, et al
JCP
Original Research
Reducing Violence Risk in Persons With Schizophrenia: Olanzapine Versus Risperidone
December 15, 2004
Jeffrey W. Swanson
,
Marvin S. Swartz
,
Eric B. Elbogen
, et al
